- Home
- ZJYL vs SGHT Comparison
ZJYL vs SGHT Comparison
Compare ZJYL & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZJYL
- SGHT
- Stock Information
- Founded
- ZJYL 2006
- SGHT 2011
- Country
- ZJYL China
- SGHT United States
- Employees
- ZJYL N/A
- SGHT N/A
- Industry
- ZJYL Industrial Specialties
- SGHT Medical Specialities
- Sector
- ZJYL Consumer Discretionary
- SGHT Health Care
- Exchange
- ZJYL Nasdaq
- SGHT Nasdaq
- Market Cap
- ZJYL 320.9M
- SGHT 304.4M
- IPO Year
- ZJYL 2023
- SGHT 2021
- Fundamental
- Price
- ZJYL $1.06
- SGHT $4.01
- Analyst Decision
- ZJYL
- SGHT Buy
- Analyst Count
- ZJYL 0
- SGHT 6
- Target Price
- ZJYL N/A
- SGHT $6.80
- AVG Volume (30 Days)
- ZJYL 323.8K
- SGHT 281.7K
- Earning Date
- ZJYL 07-26-2024
- SGHT 11-07-2024
- Dividend Yield
- ZJYL N/A
- SGHT N/A
- EPS Growth
- ZJYL N/A
- SGHT N/A
- EPS
- ZJYL 0.02
- SGHT N/A
- Revenue
- ZJYL $20,125,185.00
- SGHT $79,543,000.00
- Revenue This Year
- ZJYL N/A
- SGHT $3.06
- Revenue Next Year
- ZJYL N/A
- SGHT $10.33
- P/E Ratio
- ZJYL $56.81
- SGHT N/A
- Revenue Growth
- ZJYL 0.75
- SGHT N/A
- 52 Week Low
- ZJYL $0.56
- SGHT $2.58
- 52 Week High
- ZJYL $25.49
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- ZJYL 24.53
- SGHT 37.68
- Support Level
- ZJYL $0.96
- SGHT $3.65
- Resistance Level
- ZJYL $2.20
- SGHT $3.85
- Average True Range (ATR)
- ZJYL 0.21
- SGHT 0.28
- MACD
- ZJYL -0.05
- SGHT -0.01
- Stochastic Oscillator
- ZJYL 8.06
- SGHT 23.38
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is primarily engaged in the design, development, manufacturing, and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's products are sold to distributors in both China and in overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, nursing products, and conlo products.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.